# EDGAR Filing Document

**Accession Number:** 0001968906
**File Stem:** 0001127602-23-009693
**Filing Date:** 2023-3
**Character Count:** 5446
**Document Hash:** 9b20326b411b8529c36808a73b12a830
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-23-009693.hdr.sgml**: 20230309

**ACCESSION NUMBER**: 0001127602-23-009693

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230301

**FILED AS OF DATE**: 20230309

**DATE AS OF CHANGE**: 20230309

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Patterson Sandra
- **CENTRAL INDEX KEY:** 0001968906

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-19731
- **FILM NUMBER:** 23721356

**MAIL ADDRESS:**
- **STREET 1:** 333 LAKESIDE DRIVE
- **CITY:** FOSTER CITY
- **STATE:** CA
- **ZIP:** 94404
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GILEAD SCIENCES, INC.
- **CENTRAL INDEX KEY:** 0000882095
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 943047598
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 333 LAKESIDE DR
- **CITY:** FOSTER CITY
- **STATE:** CA
- **ZIP:** 94404
- **BUSINESS PHONE:** 6505743000

**MAIL ADDRESS:**
- **STREET 1:** 333 LAKESIDE DR
- **CITY:** FOSTER CITY
- **STATE:** CA
- **ZIP:** 94404

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GILEAD SCIENCES INC
- **DATE OF NAME CHANGE:** 19930328

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Patterson Sandra<br><sub>(Last) (First) (Middle)</sub><br>GILEAD SCIENCES, INC.<br>333 LAKESIDE DRIVE<br><sub>(Street)</sub><br>FOSTER CITY, CA 94404<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>GILEAD SCIENCES, INC. [ GILD ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-03-01 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_SVP, Controllership_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 24092 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Non-qualified Stock Option (Right to Buy) | <sup>(1)</sup> | 2032-03-10 | Common Stock | 10660 | $57.92 | D |  |
| Restricted Stock Unit | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 6629 | <sup>(3)</sup> | D |  |
| Restricted Stock Unit | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 10371 | <sup>(3)</sup> | D |  |
| Restricted Stock Unit | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 2349 | <sup>(3)</sup> | D |  |

---

### Footnotes:

(1) The shares subject to the option have a four year vesting schedule.  25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested.

(2) The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.

(3) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

(4) The restricted stock units have a three year vesting schedule.  33.33% vest on each yearly anniversary of the date of grant until fully vested.

(5) The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.

**Signature:** /s/ Amy Kim by Power of Attorney for Sandra C. Patterson  
**Date:** 2023-03-09

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**